Information:
Error:
ID
23065
Description
L-Theanine in the Management of Schizophrenia; ODM derived from: https://clinicaltrials.gov/show/NCT00372151
Link
https://clinicaltrials.gov/show/NCT00372151
Keywords
Versions (1)
- 6/21/17 6/21/17 -
Uploaded on
June 21, 2017
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Schizophrenia NCT00372151
Eligibility Schizophrenia NCT00372151
- StudyEvent: Eligibility
Similar models
Eligibility Schizophrenia NCT00372151
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Age
Item
age 18-60 years, men or women
boolean
C0001779 (UMLS CUI [1])
Schizophrenia | Schizoaffective Disorder
Item
dsm-iv criteria for schizophrenia or schizoaffective disorder
boolean
C0036341 (UMLS CUI [1])
C0036337 (UMLS CUI [2])
C0036337 (UMLS CUI [2])
Clinical Global Impression Questionnaire
Item
at least 4 on the clinical global impression scale
boolean
C3639708 (UMLS CUI [1])
Antipsychotic Agents
Item
at least two weeks of ongoing treatment with current antipsychotic agents.
boolean
C0040615 (UMLS CUI [1])
Informed Consent
Item
ability and willingness to sign an informed consent form for participation in the study.
boolean
C0021430 (UMLS CUI [1])
Nervous system disorder Serious | Endocrine System Disease Serious | Craniocerebral Trauma Severe | Epilepsy | Dementia | Cushing's disease | Thyroid Diseases | Mental Retardation | Substance Use Disorders
Item
evidence of serious neurologic or endocrine disorder, for example severe head trauma, seizure disorder, dementia, cushings disease, or thyroid disorder, mental retardation, alcohol or drug abuse.
boolean
C0027765 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0014130 (UMLS CUI [2,1])
C0205404 (UMLS CUI [2,2])
C0018674 (UMLS CUI [3,1])
C0205082 (UMLS CUI [3,2])
C0014544 (UMLS CUI [4])
C0497327 (UMLS CUI [5])
C0221406 (UMLS CUI [6])
C0040128 (UMLS CUI [7])
C0025362 (UMLS CUI [8])
C0038586 (UMLS CUI [9])
C0205404 (UMLS CUI [1,2])
C0014130 (UMLS CUI [2,1])
C0205404 (UMLS CUI [2,2])
C0018674 (UMLS CUI [3,1])
C0205082 (UMLS CUI [3,2])
C0014544 (UMLS CUI [4])
C0497327 (UMLS CUI [5])
C0221406 (UMLS CUI [6])
C0040128 (UMLS CUI [7])
C0025362 (UMLS CUI [8])
C0038586 (UMLS CUI [9])
Kidney Diseases
Item
renal disease
boolean
C0022658 (UMLS CUI [1])
Liver Dysfunction
Item
hepatic dysfunction
boolean
C0086565 (UMLS CUI [1])
Pregnancy
Item
pregnant women
boolean
C0032961 (UMLS CUI [1])
Mood stabilizing agent
Item
patients receiving mood stabilizing medications.
boolean
C1533054 (UMLS CUI [1])